Who Paid My Doc
Robert Asgharian
Obstetrics & Gynecology El Paso, TX Medical Doctor
NPI 1497834345 CMS profile 294133
9398 Viscount Blvd Ste 2A, El Paso, TX 79925
General payments
$366,042
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Robert Asgharian of El Paso, TX is reported in the CMS Open Payments database as having received $366,042 across 641 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $57,364 | 88 | |
| 2024 | General | $72,161 | 114 | |
| 2023 | General | $94,452 | 151 | |
| 2022 | General | $32,591 | 62 | |
| 2021 | General | $2,192 | 44 | |
| 2020 | General | $34,575 | 71 | |
| 2019 | General | $72,707 | 111 |
Beside peers
- Robert Asgharian
- Obstetrics & Gynecology median
- Middle half of Obstetrics & Gynecology
- National median
In program year 2025, general payments to Robert Asgharian were reported at $57,364. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.
Show as a table
| Year | Robert Asgharian | Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $72,707 | $172 | $62–$391 | $163 |
| 2020 | $34,575 | $94 | $36–$222 | $114 |
| 2021 | $2,192 | $136 | $42–$369 | $132 |
| 2022 | $32,591 | $160 | $50–$433 | $149 |
| 2023 | $94,452 | $169 | $56–$423 | $160 |
| 2024 | $72,161 | $152 | $50–$371 | $164 |
| 2025 | $57,364 | $158 | $51–$401 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
248
Drug cost
$90,694
Branded share of claims
64.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | Brand | 51 | $43,216 | |
| Gemtesa Vibegron | Brand | 43 | $42,689 | |
| Estradiol | Generic | 47 | $3,562 | |
| Tolterodine Tartrate Er Tolterodine Tartrate | Brand | 13 | $357 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 15 | $284 | |
| Progesterone Progesterone, Micronized | Brand | 15 | $192 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 23 | $167 | |
| Ibuprofen | Generic | 30 | $136 | |
| Tamsulosin Hcl | Generic | 11 | $92 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 30 billing codesPaid by Medicare
$21,607
Medicare patients
39
Services billed
165
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 46% | |
| Diabetes | 38% | |
| Chronic kidney disease | 38% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
641 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Obstetrics & Gynecology in Texas
Devin Garza
Obstetrics & Gynecology · Austin, TX
Shawn Tassone
Obstetrics & Gynecology · Austin, TX
Dale Stovall
Obstetrics & Gynecology · Dallas, TX
Karyn-Anne Cumberbatch
Obstetrics & Gynecology · Missouri City, TX
Catherine Hansen
Obstetrics & Gynecology · Webster, TX
Lisa Jukes
Obstetrics & Gynecology · Bee Cave, TX
Related records
Obstetrics & Gynecology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.